Irigoyen D, Brenes PLM, Morelos CI, Molina E

Language: Spanish
References: 10
Page:
PDF size: 132.08 Kb.

ABSTRACT

Sarcoidosis is considered a rare disease in Costa Rica. Pulmonary manifestations are the most common form of presentation. For make the diagnose is necesary a characteristic clinical picture, with the histological demonstration of noncaseating granulomas, ruling out other disease that could explain the findings. The treatment is not yet standardized, generally, will be chosen depending on the severity and extent of the disease, while some patients will require no therapy, there is a significant group which will merit. Corticosteroids represent the best initial treatment, used more every day are steroid sparing agents, in refractory cases biological therapy could be indicated. A case of a patient with symptomatic pulmonary sarcoidosis and a discussion of the main features of this entity and its therapeutic is presented.

REFERENCES

1. Dominique Valeyre et al, Sarcoidosis, Lancet 2014; 383: 1155–67

2. Alvarado A. Haryley L. Sarcoidosis. Acta Médica Costarricense 1988; 31(1):10-19.

3. Mainieri et al, Sarcoidosis: experiencia con 15 casos en el Hospital Calderón Guardia, Acta médica costarricense 2002, vol.44, n.2

4. G, Firestein et al. Kelley´s Textbook of Rheumatology, Sarcoidosis. Saunders. 2013. 117: 1898

5. Imboden et al, Current diagnosis and treatment Rheumatology, 2013, 3 ed, 397-407

6. Chen ES, et al, Etiology of sarcoidosis, Clin Chest Med, 2009;28:365

7. Jannuzzi MC et al, Sarcoidosis, N Engl Med. 2007; 357:2153

8. Marjolein Drenta et al. Pulmonology meets rheumatology in sarcoidosis: a review on the therapeutic approach. Curr Opin Rheumatol 2014, 26:000–00

9. Robert P. Baughman et al. Established and experimental medical therapy of pulmonary sarcoidosis. Eur Respir J 2013; 41: 1424–1438

10. Bradley et al, British thoracic society intersticial lung desease guideline group, et al. Intersticial lung desease guideline, Thorax 2008; 63:v1 (suppl)